Name | Title | Contact Details |
---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
eHealth Global Technologies is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed`s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology.
Comprehensive Practice Management Services is a Lincoln, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Visiting Nurse and Community Health is a Arlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.